Cholesterol-rich lipoprotein(a) is a causal factor in atherothrombosis and cardiovascular disease, independent of LDL cholesterol, other lipids, or inflammatory factors.
This Handbook, authored by Professors Nordestgaard, Chapman and Ginsberg on behalf of the European Atherosclerosis Society Consensus Panel, provides a unique reference, with a background to lipoprotein(a) biology and pathophysiology, and why it should be treated.
The Handbook deals with practical issues in measurement, provides recommendations for screening and treatment, and discusses emerging novel therapies. Case reports are a key feature to guide clinicians in their routine practice.
Supported by an Unrestricted Educational Grant from SANOFI and REGENERON.